InspireMD (NSPR) Operating Margin (2010 - 2025)
InspireMD's (NSPR) quarterly Operating Margin came in at 383.74% in Q4 2025, up 9686.0% year-on-year from 3.92% in Q4 2024, and up 25.82% quarter-over-quarter from 517.28% in Q3 2025.
InspireMD (NSPR) Operating Margin (2010 - 2025) Analysis & Trends
InspireMD's Operating Margin history runs 16 years deep, the most recent figure standing at 383.74% for Q4 2025.
- On a quarterly basis, Operating Margin rose 9686.0% year-over-year to 383.74% in Q4 2025; TTM through Dec 2025 was 552.56%, a 7456.0% decrease from a year earlier, with the FY2025 full-year figure at 552.56%, down 7456.0% from the prior year.
- Operating Margin advanced to 383.74% in Q4 2025 per NSPR's latest filing, from 517.28% in the prior quarter.
- Across five years, Operating Margin topped out at 284.86% in Q4 2021 and bottomed at 749.51% in Q1 2025.
- The 5-year median for Operating Margin is 377.79% (2021), against an average of 423.75%.
- Across the five-year window, Operating Margin surged 206831 bps in 2021 and tumbled 25884 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 284.86% in 2021, then tumbled by 69 bps to 481.09% in 2022, then soared by 31 bps to 329.81% in 2023, then sank by 46 bps to 480.61% in 2024, then climbed by 20 bps to 383.74% in 2025.
- Per Business Quant, the three latest NSPR Operating Margin figures stand at 383.74% (Q4 2025), 517.28% (Q3 2025), and 732.23% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | -383.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -383.74% |
| Sep 30, 2025 | -517.28% |
| Jun 30, 2025 | -732.23% |
| Mar 31, 2025 | -749.51% |
| Dec 31, 2024 | -480.61% |
| Sep 30, 2024 | -467.51% |
| Jun 30, 2024 | -474.99% |
| Mar 31, 2024 | -490.67% |
| Dec 31, 2023 | -329.81% |
| Sep 30, 2023 | -362.40% |
| Jun 30, 2023 | -322.32% |
| Mar 31, 2023 | -353.59% |
| Dec 31, 2022 | -481.09% |
| Sep 30, 2022 | -322.15% |
| Jun 30, 2022 | -305.75% |
| Mar 31, 2022 | -379.21% |
| Dec 31, 2021 | -284.86% |
| Sep 30, 2021 | -376.38% |
| Jun 30, 2021 | -331.41% |
| Mar 31, 2021 | -329.42% |